Sanofi-Aventis Sa (SNY)

Sanofi-Aventis Sa (SNY) Stock Price & Analysis


SNY Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$36.91 - $56.55
Previous Close$48.49
Average Volume (3M)2.50M
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)€0.00
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)16.2
Next EarningsFeb 03, 2023
Dividend Yield1.64 (2.6%)
EPS (TTM)2.99
Shares Outstanding2,508,299,634
Standard Deviation0.06
10 Day Avg. Volume2,733,809
30 Day Avg. Volume2,501,449
Price to Book (P/B)-69.12
Price to Sales (P/S)3.67
Price to Cash Flow (P/CF)29.80
P/FCF Ratio-51.90
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside32.68% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Sanofi-Aventis Sa’s price range in the past 12 months?
Sanofi-Aventis Sa lowest stock price was $36.91 and its highest was $56.55 in the past 12 months.
    What is Sanofi-Aventis Sa’s market cap?
    Currently, no data Available
    When is Sanofi-Aventis Sa’s upcoming earnings report date?
    Sanofi-Aventis Sa’s upcoming earnings report date is Feb 03, 2023 which is in 3 days.
      How were Sanofi-Aventis Sa’s earnings last quarter?
      Sanofi-Aventis Sa released its earnings results on Oct 28, 2022. The company reported $1.433 earnings per share for the quarter, beating the consensus estimate of $1.313 by $0.12.
        Is Sanofi-Aventis Sa overvalued?
        According to Wall Street analysts Sanofi-Aventis Sa’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Sanofi-Aventis Sa pay dividends?
          Sanofi-Aventis Sa pays a Annually dividend of $0.17 which represents an annual dividend yield of 2.6%. See more information on Sanofi-Aventis Sa dividends here
            What is Sanofi-Aventis Sa’s EPS estimate?
            Sanofi-Aventis Sa’s EPS estimate is $0.92.
              How many shares outstanding does Sanofi-Aventis Sa have?
              Sanofi-Aventis Sa has 2,521,671,400 shares outstanding.
                What happened to Sanofi-Aventis Sa’s price movement after its last earnings report?
                Sanofi-Aventis Sa reported an EPS of $1.433 in its last earnings report, beating expectations of $1.313. Following the earnings report the stock price went up 3.535%.
                  Which hedge fund is a major shareholder of Sanofi-Aventis Sa?
                  Among the largest hedge funds holding Sanofi-Aventis Sa’s share is Dodge & Cox. It holds Sanofi-Aventis Sa’s shares valued at 3B.


                    Sanofi-Aventis Sa Stock Smart Score

                    The Sanofi-Aventis Sa stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Sanofi-Aventis Sa

                    Founded in 1973, Sanofi is a France-based leading global healthcare company, which provides therapeutic solutions worldwide. It operates through business units including Pharmaceuticals (comprised of General Medicines and Speciality Care), Consumer Healthcare, and Vaccines.


                    Forecast EPS vs Actual EPS

                    Similar Stocks
                    Price & Change
                    Merck & Company
                    Eli Lilly & Co
                    Bristol Myers

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis